Allotment of equity shares pursuant to conversion of warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has allotted new equity shares to warrant holders who chose to convert their warrants into shares. This increases the company's total share count (dilution) but does not bring in fresh capital since the conversion price was already paid when the warrants were originally issued. Warrant conversion typically means existing warrant holders see a chance to own shares directly, which may signal confidence in the company's future price.
Shareholders may see minor dilution of their stake due to the new shares being issued. The move is largely procedural and not a sign of fundraising, though it can have a mildly positive read on promoter/investor confidence.